ArticleMarine drugs2022

Sdy-1 Executes Antitumor Activity in HepG2 and HeLa Cancer Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.

Mengyu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.